البحث | سنجن

Grace Anderson أضاف وظيفة جديدة أخرى
2025-11-05 10:33:49 -

“Rare Disease Drugs Market: Trends, Growth Drivers, and Future Outlook 2025–2035”
The rare disease drugs market is experiencing remarkable growth driven by innovations in gene therapies, RNA-based drugs, biologics, and precision medicine. In 2025, the global rare disease market size is estimated to be around $242.5 billion to $244.6 billion and is expected to nearly double or more, reaching between $374 billion and over $495 billion by the early 2030s, with a...

0 التعليقات 0 المشاركات 464 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Kaustubh Ravan أضاف وظيفة جديدة أخرى
2026-03-11 13:57:52 -

Growing Focus on Rare Disease Treatments Supporting Orphan Drugs Market Expansion
The global orphan drugs market was valued at USD 195.0 Bn in 2023 and is projected to experience steady growth over the coming years. The industry is expected to expand at a CAGR of 6.9% from 2024 to 2034, reaching USD 424.0 Bn by the end of 2034. The growth of the market is driven by increasing research and development activities for rare diseases, supportive government policies, and rising...

0 التعليقات 0 المشاركات 179 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Shim Carter أضاف وظيفة جديدة أخرى
2025-11-04 09:56:44 -

Rare Disease Therapy: Pipeline Drugs and Forecast for the Epidermal Nevus Syndrome Treatment Market.
The Epidermal Nevus Syndrome Treatment Market is a niche segment within the rare diseases and dermatology therapeutics space. Epidermal Nevus Syndrome (ENS) refers to a group of complex disorders characterized by the presence of congenital skin lesions (epidermal nevi) associated with extra-cutaneous abnormalities, often affecting the nervous, ocular, and skeletal systems. Treatment...

0 التعليقات 0 المشاركات 671 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Shim Carter أضاف وظيفة جديدة أخرى
2025-11-04 09:57:07 -

Rare Disease Therapy: Pipeline Drugs and Forecast for the Epidermal Nevus Syndrome Treatment Market.
The Epidermal Nevus Syndrome Treatment Market is a niche segment within the rare diseases and dermatology therapeutics space. Epidermal Nevus Syndrome (ENS) refers to a group of complex disorders characterized by the presence of congenital skin lesions (epidermal nevi) associated with extra-cutaneous abnormalities, often affecting the nervous, ocular, and skeletal systems. Treatment...

0 التعليقات 0 المشاركات 690 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Ksh Dbmr أضاف وظيفة جديدة Networking
2026-04-15 06:26:27 -

What Is Driving Growth in the MNGIE Treatment Market?
Regional Overview of Executive Summary Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) Market by Size and Share CAGR Value The global Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) market size was valued at USD 2.50 billion in 2024 and is expected to reach USD 3.16 billion by 2032, at a CAGR of 3.00% during the forecast period It is the necessity of this...

0 التعليقات 0 المشاركات 186 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!